secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001104659-24-056971
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell receives Nasdaq delisting notice; files appeal to stay trading
------------------------------------------------------------------------------

- Received Staff Letter on May 1, 2024 for failing to meet $1.00 minimum bid price by April 29, 2024.
- Submitted hearing request to Nasdaq Hearings Panel on May 2, 2024 to appeal delisting determination.
- Suspension and Form 25-NSE stayed pending final Panel decision; trading continues under BCLI.
- No assurance that Panel will grant an exception or that compliance will be regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924056971/0001104659-24-056971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924056971/tm2413371d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-056971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer